Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study Kuo, KHM, Layton DM, Lal A, et al. Lancet 400(10351):493-501

RT @mmanupe: We presented today at #ASH2024 the uRADAR initiative, under the scope of the RADeep Registry, in ultra rare anemia disorders f…

Congratulations to @aglente & team. A paradigm-changing publication! Mortality & risk of diabetes, liver disease, & heart disease in individuals with haemochromatosis HFE C282Y homozygosity & normal concentrations of iron, transferrin sat, or ferritin: prospective cohort study

@ASH_hematology staff, thank you for making my day and making this #ASH24 extra special